Download FREE Sample
Assisted reproductive technology (ART) refers to a set of medical procedures and techniques used to address infertility and help individuals or couples conceive a child. ART plays a significant role in modern reproductive medicine by offering solutions for a wide range of fertility challenges, enabling people to achieve parenthood when natural conception is not possible or is difficult. Overall, assisted reproductive technology includes a range of innovative approaches that aid in achieving successful pregnancies. The advancement and availability of ART have significantly improved reproductive outcomes and expanded the possibilities for parenthood today.
To learn more about this report, download the PDF brochure
Delayed parenthood and rising infertility are driving the growth of the assisted reproductive technology market
One of the primary factors driving the growth of the assisted reproductive technology market is the rising prevalence of infertility, coupled with a global trend toward delayed parenthood. Modern societal and economic dynamics, including greater emphasis on career development, higher education, and financial stability, have led individuals and couples to postpone childbearing. While these choices reflect changing lifestyles, advancing age is inherently associated with a decline in reproductive capacity for both men and women.
According to the World Health Organization (WHO), infertility affects 1 in 6 people globally, or about 17.5% of the adult population. As natural conception becomes more difficult with age, the reliance on medically assisted methods such as ART has increased signntly. ART procedures offer structured and scientifically supported solutions to overcome infertility, positioning them as an essential component in modern reproductive healthcare. Additionally, raising awareness and reduced stigma surrounding infertility have encouraged more individuals to seek medical intervention. This has resulted in a growing acceptance and normalization of assisted reproductive technology, which is further fueling market demand. To conclude, with the growing prevalence of infertility, ART has evolved from an optional treatment to a core component of reproductive healthcare services.
To learn more about this report, download the PDF brochure
Fertility preservation through egg freezing emerges as a defining trend in assisted reproductive technology
A significant emerging trend in the assisted reproductive technology market is the increasing adoption of fertility preservation techniques, particularly egg freezing. Egg freezing offers a proactive approach for those who may not be ready to conceive but wish to retain the option of having biological children later. This approach is increasingly viewed as a strategic reproductive planning tool rather than solely a medical intervention.
Advancements in cryopreservation techniques, especially vitrification, have significantly improved egg survival and fertilization rates after thawing. These improvements have enhanced trust in the procedure-s effectiveness and clinical outcomes. The appeal of egg freezing extends beyond medical necessity, attracting a broader demographic of usersas a form of reproductive insurance. Fertility clinics and healthcare providers are increasingly integrating fertility preservation services into their offerings, reflecting both growing demand and evolving patient expectations. Furthermore, broader cultural acceptance has also helped normalize the practice, making it a routine part of reproductive planning. As awareness and accessibility increase, egg freezing is becoming an integral component of ART services and a key factor shaping the future of the ART market.
Competitive Landscape Analysis
The global assisted reproductive technology market is marked by the presence of established and emerging players such as CooperSurgical Inc.; Vitrolife AB; Hamilton Thorne, Inc. (Astorg Partners); Cook Medical Inc.; Esco Micro Pte. Ltd.; Genea BIOMEDX Pty Ltd; Thermo Fisher Scientific Inc.; LENUS Pharma GesmbH; Zita West Products Ltd; Kitazato Corporation; and Exeltis USA, Inc.; among others.
Get a sample report for competitive landscape analysis
Organic and inorganic growth strategies adopted by players to establish their foothold in the market
Players operating in this market are adopting both organic and inorganic growth strategies, such as collaborations and acquisitions, to garner market share. For instance,
- In June 2024, CooperSurgical Inc. acquired ZyMt Fertility (DxNow, Inc. subsidiary). The acquisition adds ZyMt-s motile sperm separation devices to CooperSurgical-s fertility portfolio, expanding its offerings in male-factor infertility workflows used in ART procedures
- In May 2024, Vitrolife AB confirmed the acquisition of eFertility, a Netherlands-based provider of IVF clinic management software and digital witnessing systems. The acquisition broadens Vitrolife-s digital solutions portfolio and reflects increasing adoption of software-based monitoF laboratories
- In May 2023, Genea BIOMEDX and AIVF collaborated to integrate AIVF-s AI-powered embryo management platform with Genea-s time-lapse incubator systems. This collaboration aims to elevate IVF clinic performance by combining real-time embryo imaging with machine-driven analytics to improve decision-making and potentially boost clinical success rates
Report Scope
| Details | |
| Base Year Considered | 2025 |
| Historical Data | 2024 - 2025 |
| Forecast Period | 2026 - 2031 |
| 7% | |
| Market Drivers |
|
| Attractive Opportunities |
|
| Segment Scope | Type and End-user |
| Regional Scope |
|
| Key Companies Mapped | CooperSurgical Inc.; Vitrolife AB; Hamilton Thorne, Inc. (Astorg Partners); Cook Medical Inc.; Esco Micro Pte. Ltd.; Genea BIOMEDX Pty Ltd; Thermo Fisher Scientific Inc.; LENUS Pharma GesmbH; Zita West Products Ltd; Kitazato Corporation; and Exeltis USA, Inc.; among others |
| Report Highlights | Market Size & Forecast, Growth Drivers & Restraints, Trends, Competitive Analysis |
Global Assisted Reproductive Technology Market Segmentation
This report by Medi-Tech Insights provides the size of the global assisted reproductive technology market at theregional- and country-level from 2024 to 2031. The report further segments the market based on type and end-user.
Market Size & Forecast (2024-2031), By Type, USD Million
- In-Vitro Fertilization (IVF)
- Fresh Donor
- Frozen Donor
- Fresh Non-Donor
- Frozen Non-Donor
- Artificial Insemination
- Intrauterine Insemination
- Intracervical Insemination
- Intravaginal Insemination
- Intratubal Insemination
Market Size & Forecast (2024-2031), By End-user, USD Million
-
"list-style-type: none">
- Fertility Clinics
- Hospitals
- Others
Market Size & Forecast (2024-2031), By Region, USD Million
- North America
- US
- Canada
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Rest of Asia Pacific
- Latin America
- Middle East & Africa
Key Strategic Questions Addressed
- What is the market size & forecast of the assisted reproductive technology market?
- What are historical, present, and forecasted market shares and growth rates of various segments and sub-segments of the assisted reproductive technology market?
- What are the key trends defining the market?
- What are the major factors impacting the market?
- What are the opportunities prevailing in the market?
- Which region has the highest share in the global market? Which region is expected to witness the highest growth rate in the next 5 years?
- Who are the major players operating in the market?
- What are the key strategies adopted by players?
Need a More Tailored Analysis?
- Discuss the market sizing methodology and forecast assumptions with our healthcare analysts.
- Expand the scope with additional countries, market segments, technologies, or competitor profiling.
- Use the insights to support strategic planning, market entry, commercial due diligence, and long-term revenue growth initiatives.
